People: Synergy Pharmaceuticals Inc (SGYP.O)

SGYP.O on Nasdaq

3.30USD
16 Sep 2014
Price Change (% chg)

$0.02 (+0.61%)
Prev Close
$3.28
Open
$3.28
Day's High
$3.42
Day's Low
$3.26
Volume
614,796
Avg. Vol
835,787
52-wk High
$6.70
52-wk Low
$3.23

Search Stocks

Joslyn, Alan 

Brief Biography

Dr. Alan F. Joslyn is Independent Director of Synergy Pharmaceuticals Inc., since October 2009. Since August 2011, Dr. Joslyn has been a drug development consultant to Sentinella Pharmaceuticals. From August 2009 to August 2011 Dr. Joslyn served as the Chief Executive Officer of Edusa Pharmaceuticals, a privately held biotechnology company. From 2007 to 2009, Dr. Joslyn served as President and Chief Executive Officer of Mt. Cook Pharma and as Senior Vice President of Research & Development at Penwest Pharmaceuticals from 2004 to 2007. From 1995 to 2004, Dr. Joslyn held a number of leadership positions within Johnson & Johnson focusing on development of gastroenterology products including Propulsid®, Motilium®, Aciphex® and prucalopride. Dr. Joslyn received his B.S. in medicinal chemistry, B.A. in biology and Ph.D. in biochemical pharmacology from the State University of New York at Buffalo.

Basic Compensation

Total Annual Compensation, Long-Term Incentive Plans, All Other, Fiscal Year Total,
-- -- -- --

Options Compensation

  Quantity Market Value
Exercisable -- --
Unexercisable -- --
Exercised -- --
Name Fiscal Year Total

Gabriele Cerrone

739,911

Gary Jacob

920,536

Bernard Denoyer

460,302

Paul Eng

--

Marino Garcia

--

Kunwar Shailubhai

669,171
As Of 30 Dec 2013
Search Stocks